Climb Bio, Inc. (CLYM) — Institutional Holders, Q2 2026 (page 2)

109 institutional investment managers reported a CLYM position on SEC Form 13F-HR for the quarter ended June 30, 2026, with a combined reported value of $734.3M. Every filer is listed below, ranked by position value, 100 per page; this page shows ranks 101 to 109. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.

CLYM 13F holders ranked 101–109 of 109

Institutional investors reporting a position in Climb Bio, Inc. on SEC Form 13F-HR for Q2 2026, ranked by reported value.
InstitutionValueQoQ
Farther Finance Advisors#101 · 821 sh$10.7KNew
NISA INVESTMENT ADVISORS#102 · 573 sh$7.5K0.0%
Sterling Capital Management#103 · 452 sh$5.9KNew
JONES FINANCIAL COMPANIES LLLP#104 · 266 sh$3.5K0.0%
Fortitude Family Office#105 · 92 sh$1.2K0.0%
SIMPLEX TRADING#106 · 74 sh$964.00New
EverSource Wealth Advisors#107 · 47 sh$613.00New
Allworth Financial#108 · 45 sh$587.000.0%
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM#109 · 485 sh—New

Source: Form 13F-HR filings on SEC EDGAR, Q2 2026. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for Q1 2026 without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.